Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KRTX |
---|---|---|
09:32 ET | 2091 | 164.65 |
09:34 ET | 610 | 164.815 |
09:36 ET | 100 | 164.71 |
09:39 ET | 100 | 163.565 |
09:41 ET | 100 | 162.07 |
09:45 ET | 517 | 162.98 |
09:50 ET | 900 | 163.37 |
09:52 ET | 100 | 163.315 |
09:59 ET | 200 | 163.02 |
10:01 ET | 1421 | 164.15 |
10:03 ET | 500 | 163.89 |
10:06 ET | 100 | 163.81 |
10:08 ET | 131 | 163.93 |
10:10 ET | 100 | 163.59 |
10:14 ET | 300 | 163.62 |
10:28 ET | 2130 | 163.49 |
10:33 ET | 1213 | 163.155 |
10:35 ET | 600 | 163.785 |
10:37 ET | 100 | 163.48 |
10:39 ET | 200 | 163.265 |
10:42 ET | 1000 | 162.61 |
10:44 ET | 100 | 162.64 |
10:51 ET | 100 | 162.61 |
10:53 ET | 1800 | 163.34 |
10:57 ET | 100 | 163.14 |
11:00 ET | 300 | 163.2 |
11:02 ET | 400 | 163.375 |
11:04 ET | 2900 | 163.23 |
11:06 ET | 2300 | 163.76 |
11:08 ET | 1300 | 163.6 |
11:09 ET | 1510 | 163.43 |
11:11 ET | 1000 | 163.07 |
11:13 ET | 1000 | 163.525 |
11:15 ET | 400 | 163.705 |
11:18 ET | 300 | 163.5 |
11:20 ET | 100 | 163.53 |
11:22 ET | 300 | 163.53 |
11:24 ET | 200 | 163.53 |
11:26 ET | 1300 | 163.44 |
11:27 ET | 200 | 163.465 |
11:29 ET | 100 | 163.32 |
11:31 ET | 600 | 163.44 |
11:33 ET | 500 | 163.2457 |
11:36 ET | 200 | 163.45 |
11:38 ET | 200 | 163.38 |
11:42 ET | 600 | 163.355 |
11:44 ET | 1909 | 163.4 |
11:47 ET | 308 | 163.02 |
11:54 ET | 400 | 163.53 |
11:56 ET | 200 | 163.5 |
11:58 ET | 100 | 163.4225 |
12:00 ET | 130 | 163.34 |
12:02 ET | 675 | 163.485 |
12:03 ET | 600 | 163.26 |
12:05 ET | 100 | 163.35 |
12:14 ET | 300 | 163.16 |
12:16 ET | 400 | 163.42 |
12:18 ET | 637 | 163.3875 |
12:20 ET | 100 | 163.5 |
12:21 ET | 200 | 163.32 |
12:25 ET | 100 | 163.23 |
12:27 ET | 200 | 163.505 |
12:32 ET | 457 | 163.42 |
12:34 ET | 2245 | 162.93 |
12:36 ET | 100 | 163.31 |
12:39 ET | 300 | 163 |
12:41 ET | 400 | 163.25 |
12:43 ET | 200 | 163.45 |
12:45 ET | 100 | 163.295 |
12:50 ET | 868 | 163.405 |
12:56 ET | 500 | 163.5 |
12:57 ET | 4012 | 163.44 |
12:59 ET | 2950 | 164.57 |
01:01 ET | 1400 | 165.54 |
01:06 ET | 2924 | 164.985 |
01:10 ET | 500 | 165.155 |
01:14 ET | 100 | 165.41 |
01:15 ET | 400 | 165.585 |
01:17 ET | 611 | 165.41 |
01:21 ET | 100 | 165.43 |
01:24 ET | 600 | 165.02 |
01:28 ET | 300 | 164.55 |
01:32 ET | 400 | 164.94 |
01:35 ET | 100 | 164.78 |
01:37 ET | 100 | 164.78 |
01:39 ET | 897 | 164.8 |
01:42 ET | 800 | 164.68 |
01:46 ET | 800 | 164.36 |
01:48 ET | 200 | 164.21 |
01:50 ET | 400 | 164.34 |
01:55 ET | 300 | 164.055 |
01:57 ET | 100 | 164.06 |
02:04 ET | 100 | 164.015 |
02:08 ET | 100 | 163.855 |
02:09 ET | 500 | 163.78 |
02:11 ET | 100 | 163.81 |
02:13 ET | 100 | 163.76 |
02:18 ET | 300 | 163.75 |
02:20 ET | 100 | 163.3 |
02:22 ET | 110 | 163.89 |
02:24 ET | 100 | 163.43 |
02:27 ET | 800 | 163.71 |
02:36 ET | 1170 | 163.43 |
02:44 ET | 500 | 163.45 |
02:47 ET | 300 | 163.52 |
02:51 ET | 200 | 163.35 |
02:54 ET | 1100 | 163.26 |
02:58 ET | 21229 | 163.36 |
03:00 ET | 1363 | 163.495 |
03:02 ET | 12306 | 163.57 |
03:05 ET | 500 | 163.75 |
03:09 ET | 476 | 163.63 |
03:12 ET | 100 | 163.385 |
03:16 ET | 700 | 163.81 |
03:18 ET | 2980 | 164.005 |
03:20 ET | 872 | 163.31 |
03:21 ET | 300 | 163.825 |
03:23 ET | 100 | 163.56 |
03:27 ET | 4880 | 164.22 |
03:30 ET | 217 | 163.73 |
03:32 ET | 300 | 163.9 |
03:34 ET | 1066 | 164.04 |
03:36 ET | 300 | 164.525 |
03:38 ET | 150 | 164.41 |
03:39 ET | 100 | 164.44 |
03:41 ET | 300 | 164.38 |
03:43 ET | 200 | 164.48 |
03:45 ET | 1804 | 165.11 |
03:48 ET | 2430 | 165.2 |
03:50 ET | 300 | 164.98 |
03:52 ET | 800 | 164.76 |
03:54 ET | 1421 | 164.94 |
03:56 ET | 1639 | 164.93 |
03:57 ET | 3450 | 164.57 |
03:59 ET | 35983 | 164.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Karuna Therapeutics Inc | 6.2B | -16.2x | --- |
Reata Pharmaceuticals Inc | 6.6B | -57.7x | --- |
Ascendis Pharma A/S | 5.5B | -8.3x | --- |
Apellis Pharmaceuticals Inc | 5.1B | -7.4x | --- |
Vaxcyte Inc | 4.8B | -15.3x | --- |
Intra-Cellular Therapies Inc | 5.2B | -28.0x | --- |
Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its pipeline is primarily built on the therapeutic potential of its product candidate, KarXT (xanomeline-trospium), an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS), and various peripheral tissues. KarXT combines xanomeline, a novel muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the CNS. The Company is developing KarXT for the treatment of acute psychosis in adults with schizophrenia, as well as for the treatment of psychosis in Alzheimer's disease (AD). The Company is also engaged in developing its investigational TRPC4/5 candidate, KAR-2618, for the treatment of mood and anxiety disorders, and plan to provide details regarding the expected development of KAR-2618.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.2B |
---|---|
Revenue (TTM) | $6.0M |
Shares Outstanding | 37.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.09 |
EPS | $-10.15 |
Book Value | $32.67 |
P/E Ratio | -16.2x |
Price/Sales (TTM) | 1,031.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,569.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.